Date published: 2026-2-22

1-800-457-3801

SCBT Portrait Logo
Seach Input

POH1 Activators

POH1 activators are specialized chemicals designed to modulate the activity of the POH1 protein, also known as the proteasome deubiquitinating enzyme Rpn11. POH1 is a critical component of the 19S regulatory particle of the 26S proteasome, an enzymatic complex responsible for the targeted degradation of ubiquitinated proteins in eukaryotic cells. By cleaving ubiquitin moieties from proteins destined for degradation, POH1 ensures the recycling of ubiquitin and regulates the protein turnover essential for various cellular processes.

The activation of POH1 through chemical means can be achieved either directly or indirectly. Direct activators might interact with the POH1 enzyme at its active site or at allosteric sites, influencing its deubiquitinating activity. Such interaction could result in a conformational change that enhances the enzyme's catalytic efficiency, leading to an increased rate of ubiquitin cleavage from substrates. This would effectively streamline the proteasomal degradation pathway and could influence the fate of proteins that are regulated by ubiquitination. Indirect activators of POH1 may work by influencing the cellular pathways that regulate the proteasome function. These could include signaling molecules that modulate the expression levels of POH1, the assembly of the 19S regulatory particle, or the overall structure and function of the 26S proteasome. Additionally, post-translational modifications of POH1 or associated regulatory subunits, which may be affected by indirect activators, can play a role in modulating the activity and specificity of the proteasome.

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

A proteasome inhibitor that prevents protein degradation. By inhibiting the proteasome, MG-132 can indirectly enhance the necessity for deubiquitinating enzymes like POH1.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Another proteasome inhibitor that can potentially increase the demand for deubiquitinating activity of POH1.

Carfilzomib

868540-17-4sc-396755
5 mg
$41.00
(0)

An inhibitor of the 20S proteasome, influencing protein degradation processes and possibly implicating POH1 indirectly.

Ixazomib

1072833-77-2sc-489103
sc-489103A
10 mg
50 mg
$311.00
$719.00
(0)

Proteasome inhibitor that can influence the proteasomal degradation pathway, potentially affecting POH1 activity indirectly.

Lactacystin

133343-34-7sc-3575
sc-3575A
200 µg
1 mg
$188.00
$575.00
60
(2)

Known to inhibit the proteasome and could indirectly increase the demand for POH1's deubiquitinating function.

Epoxomicin

134381-21-8sc-201298C
sc-201298
sc-201298A
sc-201298B
50 µg
100 µg
250 µg
500 µg
$137.00
$219.00
$449.00
$506.00
19
(2)

A selective proteasome inhibitor that can influence the degradation pathway, potentially implicating POH1.

ONX 0914

960374-59-8sc-477437
5 mg
$245.00
(0)

Inhibits the immunoproteasome subunit LMP7 and can modulate proteasome activity, potentially influencing POH1.

Delanzomib, free base

847499-27-8sc-396774
sc-396774A
5 mg
10 mg
$160.00
$300.00
(0)

An inhibitor of the proteasome, influencing the degradation pathway and possibly affecting POH1 indirectly.

Oprozomib

935888-69-0sc-477447
2.5 mg
$280.00
(0)

A proteasome inhibitor that can modulate the degradation pathway, potentially implicating POH1.